Irina Kadiyala

Irina Kadiyala, Ph.D, is Senior Director of CGT Process Development group. She has more than 25 years of industrial experience. Her groups work was responsible for filing of multiple NDAs, as well as a BLA for Casgevy, a treatment for SCD and TDT and the first approved CRISPR-Cas9-based product. In her current position, she is heading a group focused on process development and characterization studies for new Vertex modalities.